Health condition
Congenital dyserythropoietic anaemia
Congenital dyserythropoietic anaemias (CDA) are rare inherited disorders in which red cell production is built wrongly at the factory stage, causing lifelong anaemia, jaundice and iron overload that is often mistaken for other conditions for years.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Hallmarks: lifelong anaemia, jaundice, gallstones and inappropriate iron loading
-
Marrow shows characteristically malformed red cell precursors; genetics confirms the subtype
-
Iron overload occurs even without transfusions and needs active monitoring
-
Interferon alfa improves the anaemia specifically in CDA type I
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
In CDA, the assembly line for red cells is intrinsically faulty: precursors in the marrow develop abnormal shapes and connections and mostly die before release, a process called ineffective erythropoiesis. The clinical result is a moderate anaemia that has usually been present since childhood, punctuated by jaundice and gallstones, frequently mislabelled as thalassaemia trait, spherocytosis or unexplained haemolysis until someone looks at the marrow or sends a gene panel.
Diagnosis and treatment routes
The management priorities are precision and iron. Genetic confirmation (CDAN1, SEC23B and related genes) settles the subtype, which matters because type I can respond to interferon. Ineffective erythropoiesis drives the gut to absorb iron relentlessly, so ferritin and MRI-based liver iron monitoring - and chelation when loaded - protect organs over a lifetime. Splenectomy helps selected type II patients; transfusion needs vary widely. In many parts of the UK, routine NHS referrals for this kind of problem can take months, whereas an initial appointment with a private consultant is typically available within around two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant haematologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Congenital dyserythropoietic anaemia.
Quick, plain-English answers to what people ask us most.
-
What is congenital dyserythropoietic anaemia?
Congenital dyserythropoietic anaemia (CDA) is a group of rare inherited conditions in which red blood cells develop abnormally within the bone marrow, leading to ineffective red blood cell production and a resulting chronic anaemia. There are several distinct types (CDA type I, II, and III being the main recognised forms), each with a different genetic cause and somewhat different clinical features. It typically presents from infancy or childhood, though milder forms may not be recognised until later.
-
What causes CDA?
It is caused by inherited genetic mutations affecting specific proteins important for the normal development and maturation of red blood cells within the bone marrow. Different genes are responsible for the different CDA types, with inheritance patterns varying accordingly (most commonly autosomal recessive). Genetic testing can identify the specific type and underlying mutation, which helps guide expected disease course and family counselling.
-
What symptoms does CDA cause?
Symptoms typically include chronic anaemia causing fatigue and pale skin, sometimes with jaundice (due to red blood cell breakdown) and, over time, potential complications such as iron overload from the body's compensatory responses to ineffective red cell production, and gallstones. Some types are also associated with additional physical features, particularly in CDA type II and III. Severity varies considerably between the specific types and between individuals with the same type.
-
Is CDA dangerous?
The severity varies significantly by type and individual — some people have relatively mild, well-tolerated anaemia, while others have more significant anaemia requiring regular blood transfusions, which itself carries a risk of iron overload requiring specific management over time. With appropriate, individualised specialist haematology management, most people with CDA can be well supported through their specific pattern of complications. Regular monitoring helps identify and address complications, such as iron overload, proactively.
-
How is CDA treated?
Treatment is tailored to the specific type and severity, and can include monitoring alone for milder cases, blood transfusions for more significant anaemia (alongside iron chelation therapy to manage transfusion-related iron overload), and, for some more severe cases, consideration of stem cell transplantation, which offers a potential cure for the underlying condition. Splenectomy (removal of the spleen) is sometimes considered for specific types where it can reduce transfusion needs. A specialist haematology team experienced in this rare condition typically coordinates individualised, long-term management.
-
When should I see a specialist?
See a haematologist if you or your child have unexplained chronic anaemia, particularly with jaundice or a relevant family history, for specialist assessment and testing to confirm the diagnosis and specific type. NHS haematology referral can take several weeks; a private consultation is typically available within about 2 weeks for earlier specialist assessment.